These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16689315)

  • 1. [Clinical application of gonadotrophin for IVF-ET].
    Kajihara T; Ishihara O
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():237-41. PubMed ID: 16689315
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro fertilization and embryo transfer].
    Saito H; Nakagawa K; Kojima R; Takahashi Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():80-4. PubMed ID: 16689289
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.
    Karimzadeh MA; Mashayekhy M; Mohammadian F; Moghaddam FM
    Arch Gynecol Obstet; 2011 May; 283(5):1159-64. PubMed ID: 21221982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonists.
    Macnamee MC; Howles CM; Edwards RG
    Hum Reprod; 1987 Oct; 2(7):569-71. PubMed ID: 3119660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction for in vitro fertilisation using clomiphene citrate and low-dose human menopausal gonadotrophin.
    Ronen J; Bosschieter J; Wiswedel K; Hendriks S; Levin M
    Int J Fertil; 1988; 33(2):120-2. PubMed ID: 2898449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH antagonists in poor responders.
    Kolibianakis E; Albano C; Zikopoulos K; Kahn JA; Van Steirteghem A; Devroey P
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1216-7. PubMed ID: 15548159
    [No Abstract]   [Full Text] [Related]  

  • 8. Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols.
    Johnston-MacAnanny EB; DiLuigi AJ; Engmann LL; Maier DB; Benadiva CA; Nulsen JC
    J Reprod Med; 2011; 56(1-2):12-6. PubMed ID: 21366121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.
    Ron-El R; Caspi E; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
    Int J Fertil; 1991; 36(3):157-61. PubMed ID: 1678370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on in vitro fertilization.
    Jones GS
    Endocr Rev; 1984; 5(1):62-75. PubMed ID: 6423375
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).
    Kemeter P; Feichtinger W
    Experientia; 1985 Dec; 41(12):1502-7. PubMed ID: 3935476
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovulation induction for in-vitro-fertilization and embryo transfer applying decapeptyl (DTRP-6 LH/RH) in combination with HMG or FSH.
    Mettler L; Argiriou C; Abd-el Maeboud K; Steinmüller H; Semm K
    Exp Clin Endocrinol; 1988 Mar; 92(3):245-51. PubMed ID: 2978123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study.
    Engel JB; Olivennes F; Fanchin R; Frydman N; Le Dû A; Blanchet V; Frydman R
    Reprod Biomed Online; 2003 Jun; 6(4):444-7. PubMed ID: 12831591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation induction in in vitro fertilization.
    Meirow D; Laufer N; Schenker JG
    Gynecol Endocrinol; 1992 Sep; 6(3):211-24. PubMed ID: 1442166
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between IVF and GIFT using the GnRH agonist protocol.
    Cittadini E; Palermo R; Agrifoglio V
    Acta Eur Fertil; 1988; 19(1):41-4. PubMed ID: 3137763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of various factors on in vitro fertilization (IVF) and embryo transfer in the human in clomiphene/hMG/hCG stimulated cycles].
    Baukloh V; Riedel HH; Paul S; Semm K; Mettler L
    Zentralbl Gynakol; 1985; 107(23):1409-23. PubMed ID: 3938148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve.
    Chou LL; Hwu YM; Lin MH; Lin SY; Lee RK
    Taiwan J Obstet Gynecol; 2010 Dec; 49(4):442-8. PubMed ID: 21199746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follicular activity after unilateral ovariectomy in an in vitro fertilization and embryo transfer program].
    Ventruba P; Pilka L; Cupr Z; Jirásková D
    Cesk Gynekol; 1988 Jun; 53(5):359-64. PubMed ID: 3136935
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.